Miami Jackson Memorial Hospital is a non-profit, tertiary care teaching hospital and the major teaching hospital of the University of Miami Leonard M. Miller School of Medicine located in Miami, in the United States. The hospital currently has approximately 1,550 licensed beds.

There are 1,550 beds in University of Miami, Jackson Memorial Hospital.

During the past decade, University of Miami, Jackson Memorial Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 22 clinical trials were completed, i.e. on average, 137.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 10 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Miami, Jackson Memorial Hospital" #1 sponsor was "Children's Oncology Group" with 11 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 11 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 4 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored and "Pacira Pharmaceuticals, Inc" with 3 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Miami, Jackson Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 6 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 3 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 3 trials as a collaborator and "National Institute on Drug Abuse (NIDA)" with 3 trials as a collaborator. Other collaborators include 35 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "University of Miami, Jackson Memorial Hospital" are "HIV Infections" (13 trials), "Leukemia" (5 trials), "Pain" (4 trials), "Pregnancy" (4 trials) and "Brain and Central Nervous System Tumors" (3 trials). Many other conditions were trialed in "University of Miami, Jackson Memorial Hospital" in a lesser frequency.

Most popular intervention types in "University of Miami, Jackson Memorial Hospital" are "Drug" (49 trials), "Biological" (12 trials), "Device" (11 trials), "Procedure" (6 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "filgrastim" (5 trials), "Zidovudine" (4 trials), "cyclophosphamide" (4 trials) and "etoposide" (4 trials). Other intervention names were less common.

The vast majority of trials in "University of Miami, Jackson Memorial Hospital" are 71 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "University of Miami, Jackson Memorial Hospital". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 60 completed trials in University of Miami, Jackson Memorial Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in University of Miami, Jackson Memorial Hospital, 8 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 11 trials that are defined as “Not Applicable".